Latham & Watkins Advises the Underwriters in Secondary Public Offering of Shares of Nano-X Imaging

Capital markets team advises the underwriters in the medical imaging technology company’s offering.

February 12, 2021

NANO-X IMAGING LTD (NASDAQ: NNOX), an innovative medical imaging technology company, has announced that it has priced the previously announced underwritten public offering of 3,091,635 of its ordinary shares by certain non-officer, non-director shareholders at a public offering price of US$62.50 per share.

Latham & Watkins LLP represents the underwriters in the offering with a capital markets deal team led by partners Peter Handrinos and Wesley Holmes, with associates Danny Shulman, Tyler Vivian, and Daniel Walder.

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.